These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Riccardi P, Li R, Ansari MS, Zald D, Park S, Dawant B, Anderson S, Doop M, Woodward N, Schoenberg E, Schmidt D, Baldwin R, Kessler R. Neuropsychopharmacology; 2006 May; 31(5):1016-26. PubMed ID: 16237395 [Abstract] [Full Text] [Related]
31. Sex differences in amphetamine-induced displacement of [(18)F]fallypride in striatal and extrastriatal regions: a PET study. Riccardi P, Zald D, Li R, Park S, Ansari MS, Dawant B, Anderson S, Woodward N, Schmidt D, Baldwin R, Kessler R. Am J Psychiatry; 2006 Sep; 163(9):1639-41. PubMed ID: 16946193 [Abstract] [Full Text] [Related]
32. Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity. van de Giessen E, Celik F, Schweitzer DH, van den Brink W, Booij J. J Psychopharmacol; 2014 Sep; 28(9):866-73. PubMed ID: 24785761 [Abstract] [Full Text] [Related]
33. Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Kegeles LS, Abi-Dargham A, Zea-Ponce Y, Rodenhiser-Hill J, Mann JJ, Van Heertum RL, Cooper TB, Carlsson A, Laruelle M. Biol Psychiatry; 2000 Oct 01; 48(7):627-40. PubMed ID: 11032974 [Abstract] [Full Text] [Related]
34. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients. Guardia J, Catafau AM, Batlle F, Martín JC, Segura L, Gonzalvo B, Prat G, Carrió I, Casas M. Am J Psychiatry; 2000 Jan 01; 157(1):127-9. PubMed ID: 10618027 [Abstract] [Full Text] [Related]
35. Changes in striatal D2-receptor density following chronic treatment with amphetamine as assessed with PET in nonhuman primates. Ginovart N, Farde L, Halldin C, Swahn CG. Synapse; 1999 Feb 01; 31(2):154-62. PubMed ID: 10024013 [Abstract] [Full Text] [Related]
36. Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. van Dyck CH, Seibyl JP, Malison RT, Laruelle M, Wallace E, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Charney DS, Hoffer PB. J Nucl Med; 1995 Jul 01; 36(7):1175-81. PubMed ID: 7790941 [Abstract] [Full Text] [Related]
39. Increased release of dopamine in the striata of young adults with hearing impairment and its relevance for the social defeat hypothesis of schizophrenia. Gevonden M, Booij J, van den Brink W, Heijtel D, van Os J, Selten JP. JAMA Psychiatry; 2014 Dec 01; 71(12):1364-72. PubMed ID: 25271822 [Abstract] [Full Text] [Related]
40. Striatal dopamine release in reading and writing measured with [123I]iodobenzamide and single photon emission computed tomography in right handed human subjects. Schommartz B, Larisch R, Vosberg H, Müller-Gärtner HM. Neurosci Lett; 2000 Sep 29; 292(1):37-40. PubMed ID: 10996444 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]